Orexigen Therapeutics, Inc. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Collaboration Agreements (3 contracts)
- Development Agreements (1)
- Services Agreements (3)
- Supply Agreements (3)
- AMENDED AND RESTATED COLLABORATION AGREEMENT BY AND BETWEEN OREXIGEN THERAPEUTICS, INC. AND TAKEDAPHARMACEUTICAL COMPANY LIMITED DATED July 31, 2015 (Filed With SEC on November 9, 2015)
- AMENDEDAND RESTATED NALTREXONE HYDROCHLORIDE SUPPLY AGREEMENT (Filed With SEC on August 7, 2015)
- AMENDMENT NO. 2 TO MANUFACTURING SERVICES AGREEMENT SEPTEMBER 11, 2014 (Filed With SEC on February 27, 2015)
- AMENDMENT NO. 1 TO MANUFACTURING SERVICES AGREEMENT NOVEMBER 1, 2013 (Filed With SEC on March 13, 2014)
- AMENDMENT NUMBER 1 TO COLLABORATION AGREEMENT (Filed With SEC on March 13, 2014)
- NALTREXONE HYDROCHLORIDE SUPPLY AGREEMENT (Filed With SEC on March 13, 2014)
- COLLABORATION AGREEMENT BY AND BETWEEN OREXIGEN THERAPEUTICS, INC. AND TAKEDA PHARMACEUTICAL COMPANY LIMITED DATED SEPTEMBER 1, 2010 TABLE OFCONTENTS (Filed With SEC on November 4, 2010)
- Manufacturing Services Agreement March 12, 2010 Table of Contents (Filed With SEC on May 10, 2010)
- AMENDED AND RESTATED MASTER AGREEMENT FOR PHARMACEUTICAL DEVELOPMENT SERVICES (Filed With SEC on May 10, 2010)
- BUPROPION HYDROCHLORIDE SUPPLY AGREEMENT (Filed With SEC on March 11, 2010)